Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its fourth-quarter and full-year 2023 financial results on Wednesday, Feb. 21, 2024. Bausch + Lomb will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch + Lomb website prior to the start of the call.

Conference Call Details

Date: Wednesday, Feb. 21, 2024
Time: 8 a.m. ET
Participant Event Dial-in: +1 (888) 506-0062 (North America)

+1 (973) 528-0011 (International)

Participant Access Code: 181271
Replay Dial-in: +1 (877) 481-4010 (North America)

+1 (919) 882-2331 (International)

Replay Passcode: 49630 (replay available until March 6, 2024)

About Bausch + Lomb

Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Its comprehensive portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,000 employees and a presence in nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario with corporate offices in Bridgewater, New Jersey. For more information, visit and connect with us on XLinkedInFacebook and Instagram.

© 2024 Bausch + Lomb.



Media Contact:
T.J. Crawford
(908) 705-2851